Floatz logo

Pioglitazone

Healthy

Merck Sharp & Dohme LLCSmall moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

9 Active assets in the Healthy cohort.

Asset / SponsorPhaseRating
Benserazide
University Hospital Muenster
Phase 4B
PANITUMUMAB
Universitaire Ziekenhuizen KU Leuven
Phase 4B
Doxycycline
Universitaire Ziekenhuizen KU Leuven
Phase 4B
Humulin R
Columbia University
Phase 1CCC
Sra-333
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1CC

View all 25 →

Same molecule, other indications

Pioglitazone is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →